Skip to main content

Events

Science Salons

Intimate monthly dinner events with top scientific thinkers, providing unparalleled access to advanced knowledge, elite networking opportunities, and personalized strategic advice.

Explore upcoming events featuring expert scientific researchers and speakers, aimed at fostering discussions and enriching your scientific knowledge.

The Academy is proud to offer a curated selection of past events for on-demand viewing. Check out our past events calendar to access resources, recordings, and more.

Discussion Groups

Discussion Groups present half- and one-day symposia throughout the year in a given area, seeking to reflect the dynamism of scientific fields of relevance to our global community. Steering Committees composed of multi-institutional scientists from the Academy’s network shape each Discussion Group’s portfolio of events and publications, providing thought leadership on key issues of interest. Our Discussion Groups focus on the following scientific disciplines:

Biochemical Pharmacology Discussion Group

Understanding drug action at the frontiers of modern drug design

The Biochemical Pharmacology Discussion Group advances our fundamental knowledge of the activity and metabolism of both small molecules and biologics at the biochemical and molecular levels. Research spans chemotherapy, neuropharmacology, antimicrobials, inflammation, and immunopharmacology, as well as gastrointestinal, cardiovascular, and endocrine pharmacology and toxicology. The group also serves as the Biochemical Topical Group for the American Chemical Society’s New York Chapter.

Biochemical Pharmacology Steering Committee Members

Lynn M. Abell, PhD Kojin Therapeutics

Magdalena Alonso-Galicia, PhD Roivant Sciences

Joshua Apgar, PhD Applied BioMath

Mercedes Beyna, MS Biogen

Scott Brodeur, PhD Janssen Research and Development

Megan Dow, PhD Biohaven Pharmaceuticals

Steven Gross, PhD Weill Cornell Medical College

John Hambor, PhD Boehringer Ingelheim

Julia Heinrich, PhD Bristol-Myers Squibb

Andres Hurtado-Lorenzo, PhD Crohn’s & Colitis Foundation

Katalin Kauser, MD, PhD, DSc Alucent

Christine Grimaldi, PhD Boehringer Ingelheim

Scott MacDonnell, PhD Regeneron Pharmaceuticals, Inc.

Marco Prunotto, PhD Galapagos

Claire M. Steppan, PhD Pfizer

George Zavoico, PhD Cue Biopharma

Brain and Behavior Discussion Group

Unlocking the secrets of the human brain

The Brain and Behavior Discussion Group advances fundamental knowledge about the brain and nervous system, providing the foundation for novel ways to reduce the burden of neurological disease.

Brain and Behavior Steering Committee Members

Howard Fillit, MD Alzheimer’s Drug Discovery Foundation

Kevin Lee, PhD The Lawrence Ellison Foundation; Grace Science Foundation

John Spiro, PhD Simons Foundation

Gregory Petsko, D.Phil Weill Cornell Medical College

Cancer Discussion Group

Advancing the world’s most promising research in cancer prevention, diagnosis, care, and cure

The Cancer Discussion Group advances fundamental knowledge of basic, translational, clinical, and diagnostic aspects in the field, with the goal of surfacing breakthroughs in cancer prevention, diagnosis, care and cure.

Cancer Steering Committee Members

Joan Massagué, PhD Memorial Sloan Kettering Cancer Institute

Michael A. White, PhD Pfizer

George Zavoico, PhD Cue Biopharma

Chemical Biology Discussion Group

Chemical tools providing insight into biological function

Our portfolio of events and publications in Chemical Biology encompasses chemistry-based technology— such as proteomics, lipidomics, metabolomics, and glycomics—as well as synthetic and systems biology work when inspired and supported by chemical tools or aimed at engineering biological systems to perform a new type of chemical transformation. The Chemical Biology Discussion Group also serves as the Organic Topical Group for the American Chemical Society’s New York Chapter.

Chemical Biology Steering Committee Members

Paramjit Arora, PhD New York University

Elizabeth Boon, PhD Stony Brook University

David M. Chenoweth, PhD University of Pennsylvania

Justin Cisar, PhD Janssen Research & Development

Pamela Chang, PhD Cornell University

Virginia Cornish, PhD Columbia University

Yael David, PhD Memorial Sloan Kettering Cancer Center

Christopher am Ende, PhD Pfizer Inc.

Robert P. Fisher, MD, PhD Mount Sinai School of Medicine

Kevin Gardner, PhD CUNY Advanced Science Research Center

Catherine L. Grimes, PhD University of Delaware

Akira Kawamura, PhD CUNY – Hunter College

Jon Lai, PhD Albert Einstein College of Medicine

Thomas Leyh, PhD Albert Einstein College of Medicine

Tania Lupoli, PhD New York University

Jin Kim Montclare, PhD Polytechnic Institute of New York University

Allie Obermeyer, PhD Columbia University

E. James Petersson, PhD University of Pennsylvania

Scott Priestley, PhD Bristol-Myers Squibb R&D

Deborah Rothman, PhD Merck & Co Inc.

David Sabatino, PhD Seton Hall University

Mohammad R. Seyedsayamdost, PhD Princeton University

Neel H. Shah, PhD Columbia University

Sarah Slavoff, PhD Yale University

Derek S. Tan, PhD Memorial Sloan Kettering Cancer Center

Ekaterina (Katya) Vinogradova, PhD Rockefeller University

Neal J. Zondlo, PhD University of Delaware

CRISPR Discussion Group

Revolutionizing gene editing

The CRISPR Discussion Group advances our understanding of the cellular, molecular, and biochemical pathways of CRISPR-associated proteins, DNA repair pathways, and their applications in diverse organisms, including for human health and disease biology.

CRISPR Steering Committee Members

Britt Adamson, PhD Princeton University

Maria Jasin, PhD Memorial Sloan Kettering Cancer Center

Neville Sanjana, PhD New York University and New York Genome Center

Samuel Sternberg, PhD Columbia University

Genome Integrity Discussion Group

Protecting the code of life

Our portfolio of events and publications in Genome Integrity seek to successfully map the mechanisms by which these regulatory processes act or go awry, presenting an exciting avenue for identifying novel approaches for protecting against disease-causing errors and restoring function.

Genome Integrity Steering Committee Members

Scott Keeney, PhD Memorial Sloan Kettering Cancer Center

Susan L. Smith, PhD NYU School of Medicine

Jean Gautier, PhD, Columbia University Irving Medical Center

Agata Smogorzewska, MD, PhD The Rockefeller University

Machine Learning Discussion Group

Pattern recognition wizardry — from Siri to self-driving cars

The Machine Learning Discussion Group has held symposia for the better part of two decades to discuss advanced research related to such topics. Participants come from a variety of disciplines and from both academic and industry institutions, promoting the exchange of new insights between communities.

Machine Learning Steering Committee Members

Naoki Abe, PhD IBM Research

Corinna Cortes, PhD Google Research

Jennifer L. Costley, PhD The New York Academy of Sciences

Patrick Haffner, PhD Interactions Corporation

Elad Hazan, PhD Princeton University

Tony Jebara, PhD Columbia University

John Langford, PhD Microsoft Research

Mehryar Mohri, PhD Courant Institute of Mathematical Sciences, New York University

Alexander Rakhlin, PhD University of Pennsylvania

Robert Schapire, PhD Microsoft Research

Microbiology and Infectious Diseases Discussion Group

Preparing to fight tomorrow’s disease outbreaks, today

Our portfolio of events and publications in Microbiology and Infectious Diseases is designed to surface new discoveries and tackle current challenges in biomedical research and public health efforts to understand, treat, control, and prevent over 200 known infectious diseases. Beyond a better understanding of infectious disease etiology, epidemiology, diagnosis, and care, we also explore broader issues such as the roles that human demographics and behavior, international travel and commerce, technology and industry, economic development, microbial adaptation and change, and the breakdown of public health measures play in the complex coexistence of microbes and man.

Microbiology and Infectious Diseases Steering Committee Members

Annaliesa S. Anderson, PhD Pfizer

Doris Bucher, PhD New York Medical College

Nancy Connell, PhD Rutgers New Jersey Medical School

Johanna P. Daily, MD Albert Einstein College of Medicine

Matthew Evans, PhD Icahn School of Medicine and Mount Sinai

Vincent Fischetti, PhD The Rockefeller University

Allan Goldberg, PhD Avacyn Pharmaceuticals, Inc.

Lorrence Green, PhD Westbury Diagnostics, Inc

Takushi Kaneko, PhD TB Alliance

Barry Kreiswirth, PhD Rutgers New Jersey Medical School

W. Ian Lipkin, MD Columbia University

Stephen Morse, PhD Columbia University

Paul Offit, MD Children’s Hospital of Philadelphia

David Perlin, PhD Public Health Research Institute, New Jersey Medical School/ Rutgers Biomedical and Health Sciences

Shirley Raps, PhD Hunter College, City University of New York

Yegor Voronin, PhD Global HIV Vaccine Enterprise

Michael Watson, MD Moderna Therapeutics

Microbiome Science Discussion Group

Your body is mostly microbes

Our portfolio of events and publications in Microbiome Science are designed to surface new discoveries and tackle current challenges including the development of reference sets of microbial genome sequences, understanding the complexity of the microbial community at various body sites, determining the relationship between human health, disease, and changes in the microbiome, new tools and technologies for microbiome sample collection and computational analyses, and the ethical, legal, and social implications of studying and modifying the human microbiome.

Microbiome Science Steering Committee Members

David Artis, PhD Weill Cornell Medicine

Martin Blaser, MD New York University

John Hambor, PhD Boehringer Ingelheim

Dan Littman, MD, PhD New York University

Eric G. Pamer, MD Memorial Sloan Kettering Cancer Center

Paul Planet, MD, PhD Children’s Hospital of Philadelphia

Nilufer Seth, PhD Pfizer

Physical Sciences, Sustainability and Engineering Discussion Group

Advancing technology for sustainable solutions

The Physical Sciences, Sustainability and Engineering Discussion Group brings together international experts and partners from academia, industry, government and beyond, for programs that provide a neutral forum for exploring cutting-edge topics, exchanging information and forming collaborations on groundbreaking initiatives.

Innovations in AI and Higher Education, with Reid Hoffman and Nicholas B. Dirks

Join author Reid Hoffman and the Academy’s CEO Nicholas B. Dirks for a discussion about the potential of AI, especially the powerful Large Language Models like GPT-4, in shaping the future of education, business, and creativity—and Hoffman’s new book, Impromptu: Amplifying Our Humanity Through AI.

Through this interactive exploration, readers witness a compelling vision of the future, where AI becomes not a threat but a transformative partner, unlocking the full potential of humanity. Impromptu is an invitation to join the conversation on shaping our collaborative journey into an AI-powered destiny. Explore solutions, navigate uncertainties, and contribute to the evolving narrative of humanity’s partnership with GPT-4.

The discussion will also focus on the state of higher education in the US, in conjunction with the release of Nick Dirks’ newest book, City of Intellect: The Uses and Abuses of the University.

About the Author

Reid Hoffman is the co-founder of LinkedIn, co-founder of Inflection AI, and a partner at Greylock. He currently serves on the boards of companies such as Aurora, Coda, Convoy, Entrepreneur First, Joby, Microsoft, Nauto, and Neeva. He also serves on nonprofit boards, such as Kiva, Endeavor, CZI Biohub, New America, Berggruen Institute, Opportunity@Work, the Stanford Institute for Human-Centered AI, the MacArthur Foundation’s Lever for Change, and The New York Academy of Sciences.

He is the host of the podcasts Masters of Scale and Possible. He is the co-author of four best-selling books: The Startup of You, The Alliance, Blitzscaling, and Masters of Scale. He earned a master’s degree in philosophy from Oxford University, where he was a Marshall Scholar and a bachelor’s degree with distinction in symbolic systems from Stanford University.

Pathways to Success: Effective Mentorship in STEM

Mentorship is a collaborative learning relationship that benefits all participants. In fact, effective mentorship is a key factor contributing to a high rate of degree attainment, increased social and self awareness, sharper communication skills, career satisfaction, and other benefits that last for many years.

The New York Academy of Sciences is thrilled to partner with the National Research Mentoring Network (NRMN) to provide a free online webinar highlighting the potential and importance of effective mentorship in STEM. NRMN’s mission is to provide researchers across all career stages in the biomedical, behavioral, clinical, and social sciences with the evidence-based mentorship and professional development programming that emphasizes the benefits and challenges of diversity, inclusivity and culture. 

This event is tailored for individuals at all ages and professional levels looking to enrich their career through collaborating and learning from a mentor or mentee, and for anyone interested in sharing this information with their network. Join us and learn from experts in the field about how effective mentorship can benefit you and your community.

Ross Prize Symposium 2024

The annual Ross Prize in Molecular Medicine is established in conjunction with the Feinstein Institutes for Medical Research and Molecular Medicine. The winner will be an active investigator having produced innovative, paradigm-shifting research that is worthy of significant and broad attention in the field of molecular medicine. We expect this individual will continue to garner recognition in future years, and that their current accomplishments reflect a rapidly rising career trajectory of discovery and invention. 

Expert Speaker Talk Lurie Prize Winners 2023 Presented by FNIH and NYAS

Embark on an exhilarating journey into mitochondrial breakthroughs with 2023 Lurie Prize Winners, Drs. Chandel and Mootha. Uncover Dr. Chandel’s revelations on mitochondria as powerful influencers of our daily functions and disease and learn about Dr. Mootha’s, MitoCarta. Following the talk, participants are invited to dive into a Q+A session and connect with Drs. Chandel and Mootha directly. Register now for this thrilling night of cutting-edge science, discoveries, and insights.

Frontiers in Immunology

Technological developments such as next-generation sequencing, super-resolution imaging, and systems-level computational approaches have resulted in great leaps in our understanding of the immune system. Despite these advances, many autoimmune diseases lack effective treatments; and the current pandemic has shown the critical need to better understand the immune system in order to harness it to develop vaccines and therapeutics.

Therapeutic Promise of the Microbiome: The Dr. Paul Janssen Award Symposium

Developing targeted therapies for rare cardiomyopathies is challenging: difficulties identifying patients, delivering therapeutics, and accessing heart tissue results in a 50% mortality rate 5 years after diagnosis.  Early, accurate disease detection and classification can significantly improve outcomes for patients with rare cardiomyopathies. Achieving these goals requires multiple novel technologies to coalesce that will enable early patient identification, deepen our understanding of the disease process, improve modeling of human pathophysiology, accelerate testing of drug candidates, and leverage novel therapeutic modalities to target the heart specifically, safely and effectively.

This two-day conference will convene industry scientists, academics, and clinicians to understand the integration of artificial intelligence and engineered tissues for safe and effective delivery of novel therapeutics for patients with arrhythmogenic, hypertrophic, and dilated cardiomyopathies.